血液分析服务提供商aescolab获得融资，由KRING领投-动脉网

Berlin-based blood analysis innovator aescolab secures new capital

D-Pharm 等信源发布 2025-06-23 08:47



可切换为仅中文







aescolab, a Berlin-based healthtech innovator that uses AI to deliver personalized

aescolab，一家总部位于柏林的健康科技创企，利用人工智能提供个性化服务

health

健康

analysis and lifestyle recommendations based on blood values, has closed a new round of funding to accelerate its growth. The investment will help the company grow its presence in Germany and expand into international markets.

基于血液值的分析和生活方式建议，已完成新一轮融资以加速其增长。这笔投资将有助于该公司在德国的发展，并进军国际市场。

The round was led by founding investor KRING, an ESG impact fund based in Copenhagen, which reaffirmed its confidence in aescolab's scalable, technology-driven approach to prevention and workplace health promotion

本轮融资由总部位于哥本哈根的创始投资者KRING领投，这是一家专注于ESG影响的基金，再次表明了其对aescolab可扩展的技术驱动型预防和职场健康促进方法的信心。

'aescolab represents exactly the kind of meaning-driven, data-driven innovation we support,' said Martin Kring, founder of KRING. 'aescolab has proven that scalable, technology-enabled tools can lead to real improvements in human health - exactly the impact ESG capital should make.'

“aescolab 代表了我们支持的那种以意义为导向、以数据为驱动的创新，”KRING 创始人马丁·克林 (Martin Kring) 表示，“aescolab 已经证明，可扩展的技术工具能够带来人类健康的真正改善，这正是 ESG 资本应该产生的影响。”

Since its launch in May 2024, aescolab has already supported over 1,000 people and is actively working with several leading German companies to integrate blood-based health data into holistic employee health strategies.

自 2024 年 5 月推出以来，aescolab 已支持超过 1,000 人，并正在与几家德国领先公司积极合作，将基于血液的健康数据整合到整体员工健康战略中。

The platform analyzes key blood

该平台分析关键血液

biomarkers

生物标志物

and creates personalized health reports - with clear, actionable recommendations for companies and individuals. The company's goal is to establish itself as a leading health partner for organizations that see the health of their employees as a strategic priority - while empowering employees to take responsibility for their own health..

并创建个性化的健康报告 - 提供清晰、可操作的建议，面向公司和个人。该公司的目标是成为那些将员工健康视为战略重点的组织的主要健康合作伙伴 - 同时赋予员工对自身健康负责的能力。

'We want to be a reliable partner for forward-looking companies in Germany and throughout Europe,' said Stephan Alexander Dreier, CEO of aescolab. 'aescolab shows how AI and automation can solve one of the most pressing problems of the modern working world: Keeping people healthy and productive. For HR and OHM managers, we offer a new, data-driven approach to reduce sick days, increase energy levels and strengthen the employer brand.

“我们希望成为德国乃至整个欧洲前瞻性公司的可靠合作伙伴，”aescolab首席执行官Stephan Alexander Dreier表示。“aescolab展示了人工智能和自动化如何解决现代工作世界中最紧迫的问题之一：保持员工的健康和生产力。对于人力资源和职业健康管理经理，我们提供了一种新的、数据驱动的方法来减少病假、提高能量水平并增强雇主品牌。”

With this funding, we can scale our impact and help even more companies and employees to make health measurable, personalized and effective..

通过这笔资金，我们可以扩大影响力，帮助更多公司和员工实现健康可衡量、个性化且行之有效。

At the heart of aescolab's mission is the belief that understanding one's blood values is the foundation for sustainable health. With a focus on prevention, personalization and performance, the company positions itself as a strategic healthcare partner for forward-thinking employers - and as a promising player in the changing European healthtech market..

Aescolab使命的核心是相信了解自己的血液指标是实现可持续健康的基础。该公司专注于预防、个性化和性能，将自己定位为前瞻性雇主的战略医疗保健合作伙伴，并成为欧洲不断变化的健康技术市场中一个有前途的竞争者。

With the current financing round, aescolab reaches a total investment volume in the seven-digit range.

通过本轮融资，aescolab的总投资额达到了七位数。

To support the next growth phase, aescolab brings on board several renowned investors and advisors from the fields of technology, strategy and healthcare:

为了支持下一阶段的增长，aescolab引入了来自科技、战略和医疗领域的多位知名投资者和顾问：

aescolab - Partner for blood analysis in BGM

aescolab - BGM 血液分析合作伙伴

René Svendsen-Tune (former CEO GN Store Nord / Jabra; EVP, Nokia Networks) - as Chairman of the Board

董事会主席：雷内·斯文森-图恩（前GN Store Nord/Jabra首席执行官；诺基亚网络执行副总裁）

Jens Bjørn Andersen (former CEO, DSV) - Member of the Board of Directors

延斯·比约恩·安德森（前首席执行官，DSV）- 董事会成员

Dr. Patrick Simon (former Senior Partner, McKinsey Germany; member of the Global McKinsey Health Institute Leadership Team)

帕特里克·西蒙博士（前麦肯锡德国高级合伙人；全球麦肯锡健康研究所领导团队成员）

Dr. Cyrus Alamouti, experienced healthtech strategist and investor

赛勒斯·阿拉穆蒂博士，经验丰富的健康科技战略家和投资者

KRING, founding investor and ESG-oriented impact fund

KRING，创始投资者和ESG导向的影响基金

'aescolab's model addresses a real and growing need - precisely, quickly and effectively,' said René Svendsen-Tune. 'The team, mission and technology are perfectly aligned - I look forward to actively shaping the next chapter as Chairman.'

“aescolab的模型满足了一个真实且不断增长的需求——精确、快速且高效，”René Svendsen-Tune表示。“团队、使命和技术完美契合——我期待作为主席积极参与塑造下一个篇章。”

Note: This article has been translated using a computer system without human intervention. LUMITOS offers these automatic translations to present a wider range of current news. Since this article has been translated with automatic translation, it is possible that it contains errors in vocabulary, syntax or grammar.

请注意：本文已使用计算机系统进行翻译，无人工干预。LUMITOS 提供这些自动翻译，以呈现更广泛的当前新闻。由于本文是通过自动翻译翻译的，因此可能会包含词汇、句法或语法方面的错误。

The original article in German can be found .

德语原文可以在以下位置找到。

here

这里

。

https://www.bionity.com/en/news/1186524/berlin-based-blood-analysis-innovator-aescolab-secures-new-capital.html

https://www.bionity.com/zh/news/1186524/柏林血液分析创新公司aescolab获得新资本.html

Biomarkers indicate health in old age

生物标志物指示老年健康状况

Researchers can determine the disease vulnerability of older people using a defined set of substances in the blood

研究人员可以使用血液中一组特定的物质来确定老年人的疾病易感性。